Retraction. Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
Br J Cancer
.
2012 Dec 4;107(12):2024.
doi: 10.1038/bjc.2012.497.
Authors
A Gualberto
,
M L Hixon
,
D D Karp
,
D Li
,
S Green
,
M Dolled-Filhart
,
L G Paz-Ares
,
S Novello
,
J Blakely
,
C J Langer
,
M N Pollak
PMID:
23211971
PMCID:
PMC3516686
DOI:
10.1038/bjc.2012.497
No abstract available
Publication types
Retraction of Publication